Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
Standard
Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms. / Moritz, Steffen; Veckenstedt, Ruth; Randjbar, Sarah; Vitzthum, Francesca; Woodward, T S.
In: PSYCHOL MED, Vol. 41, No. 9, 9, 2011, p. 1823-1832.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
AU - Moritz, Steffen
AU - Veckenstedt, Ruth
AU - Randjbar, Sarah
AU - Vitzthum, Francesca
AU - Woodward, T S
PY - 2011
Y1 - 2011
N2 - Although antipsychotic medication still represents the treatment of choice for schizophrenia, its objective impact on symptoms is only in the medium-effect size range and at least 50% of patients discontinue medication in the course of treatment. Hence, clinical researchers are intensively looking for complementary therapeutic options. Metacognitive training for schizophrenia patients (MCT) is a group intervention that seeks to sharpen the awareness of schizophrenia patients on cognitive biases (e.g. jumping to conclusions) that seem to underlie delusion formation and maintenance. The present trial combined group MCT with an individualized cognitive-behavioural therapy-oriented approach entitled individualized metacognitive therapy for psychosis (MCT+) and compared it against an active control.
AB - Although antipsychotic medication still represents the treatment of choice for schizophrenia, its objective impact on symptoms is only in the medium-effect size range and at least 50% of patients discontinue medication in the course of treatment. Hence, clinical researchers are intensively looking for complementary therapeutic options. Metacognitive training for schizophrenia patients (MCT) is a group intervention that seeks to sharpen the awareness of schizophrenia patients on cognitive biases (e.g. jumping to conclusions) that seem to underlie delusion formation and maintenance. The present trial combined group MCT with an individualized cognitive-behavioural therapy-oriented approach entitled individualized metacognitive therapy for psychosis (MCT+) and compared it against an active control.
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Questionnaires
KW - Severity of Illness Index
KW - Schizophrenic Psychology
KW - Treatment Outcome
KW - Cognition
KW - Awareness
KW - Cognitive Therapy/methods
KW - Psychiatric Status Rating Scales/statistics & numerical data
KW - Antipsychotic Agents
KW - Delusions/psychology/therapy
KW - Patient Compliance/psychology/statistics & numerical data
KW - Psychotherapy, Group/methods
KW - Schizophrenia/therapy
KW - Adult
KW - Humans
KW - Male
KW - Female
KW - Questionnaires
KW - Severity of Illness Index
KW - Schizophrenic Psychology
KW - Treatment Outcome
KW - Cognition
KW - Awareness
KW - Cognitive Therapy/methods
KW - Psychiatric Status Rating Scales/statistics & numerical data
KW - Antipsychotic Agents
KW - Delusions/psychology/therapy
KW - Patient Compliance/psychology/statistics & numerical data
KW - Psychotherapy, Group/methods
KW - Schizophrenia/therapy
M3 - SCORING: Journal article
VL - 41
SP - 1823
EP - 1832
JO - PSYCHOL MED
JF - PSYCHOL MED
SN - 0033-2917
IS - 9
M1 - 9
ER -
